Determinants fo Undertreatment Amoung Patients with Chronic Obstructive Pulmonary Disease

ID Number 08-1257

Principal Investigator(s)
Juan Wisnivesky

Department(s) or Division(s)
General Internal Medicine


Chronic obstructive pulmonary disease (COPD) is a leading cause of death in the United States and represents a major health, social, and economic burden. Despite strong evidence regarding the benefits of pharmacologic treatment on symptoms, quality of life, morbidity, and mortality, there is widespread undertreatment of patients with COPD. The overall goal of this study is to improve the treatment and outcomes of patients with COPD by evaluating the proportion of outpatients with COPD that receive guideline concordant treatment and identifying predictors of lack of guideline concordant care with a particular focus on the role of the patient’s race and ethnicity.

Contact Information
Linda Lurslurchachai
(212) 824-7498

Recruiting Patients: Yes